Meridian Bioscience, Inc. Appoints Jack Kenny as Chief Executive Officer
October 10, 2017 11:50 ET
|
Meridian Bioscience, Inc.
CINCINNATI, Oct. 10, 2017 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ:VIVO) today announced that it has appointed John (Jack) P. Kenny as Chief Executive Officer, effective October 9,...
Meridian Contributes to Upcoming “LEADCON 2017” – Third Annual International Conference on the Prevention of Lead and Heavy Metal Toxicity in Hyderabad, India
September 19, 2017 09:00 ET
|
Meridian Bioscience, Inc.
CINCINNATI, Sept. 19, 2017 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ:VIVO) today announced that Magellan Diagnostics, Inc., a business unit of Meridian, will support and participate in...
Meridian Launches TRU Block® ULTRA – A Powerful Immunoassay Interference Blocker
September 05, 2017 14:22 ET
|
Meridian Bioscience, Inc.
CINCINNATI, Sept. 05, 2017 (GLOBE NEWSWIRE) -- Meridian Life Science, Inc., (MLS) of Memphis, Tennessee, a wholly-owned subsidiary of Meridian Bioscience, Inc. (NASDAQ:VIVO) today announced the...
Meridian Initiates Clinical Trials for New Neonatal Saliva CMV illumigene Test
August 09, 2017 13:30 ET
|
Meridian Bioscience, Inc.
CINCINNATI, Aug. 09, 2017 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ:VIVO) today announced that it has initiated clinical trials for a new illumigene CMV molecular amplification test....
Meridian Bioscience Introduces the Expansion of Its ImmunoCard STAT!® Product Line
August 08, 2017 14:31 ET
|
Meridian Bioscience, Inc.
CINCINNATI, Aug. 08, 2017 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ:VIVO) today announced the expansion of its ImmunoCard STAT!® product line with the addition of ImmunoCard STAT! FLU...
Meridian Bioscience Elects John Rice to the Board of Directors
August 08, 2017 10:00 ET
|
Meridian Bioscience, Inc.
CINCINNATI, Aug. 08, 2017 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ:VIVO) today announced that its Board of Directors elected a new independent director, John M. Rice, Ph.D., effective...
Bioline Launches New JetSeq™ Clean Kit for Next-Generation Sequencing
August 02, 2017 11:05 ET
|
Meridian Bioscience, Inc.
CINCINNATI, Aug. 02, 2017 (GLOBE NEWSWIRE) -- Bioline, The PCR Company, a wholly-owned subsidiary of Meridian Bioscience, Inc. (NASDAQ:VIVO) today announced the further expansion of the JetSeq™...
Meridian Bioscience Reports Third Fiscal Quarter 2017 Operating Results, Including Non-Cash Goodwill Impairment Charge,Declares Regular Cash Dividend, and Reaffirms Fiscal 2017 Guidance Excluding the Effect of Goodwill Impairment Charge
July 27, 2017 07:45 ET
|
Meridian Bioscience, Inc.
GENERAL HIGHLIGHTS CINCINNATI, July 27, 2017 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ:VIVO) today: reported fiscal 2017 third quarter and first nine months net revenues of $50.1 and...
Meridian Announces Wholly Foreign Owned Enterprise (WFOE) Office in Beijing, China
July 20, 2017 12:30 ET
|
Meridian Bioscience, Inc.
CINCINNATI, July 20, 2017 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ:VIVO) today announced the opening of Meridian Bioscience Beijing, LLC, its wholly foreign owned enterprise (WFOE) in...
Meridian Bioscience Comments on Recent FDA Press Statement
July 13, 2017 13:37 ET
|
Meridian Bioscience, Inc.
CINCINNATI, July 13, 2017 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ:VIVO). Meridian Bioscience, Inc. is providing the following comments regarding the FDA press statement and website...